Home›Companies›Healthcare›Vignette Bio

Vignette Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 13, 2024·Suggest an edit

About Vignette Bio

Vignette Bio is a private company based in San Diego, California, incorporated in 2023 in Delaware. It has reported $105,000,000 raised in one offering on Form D since September 2024. Its chief executive is Kenneth Song, M.D..

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 17, 2024Sep 13, 2024$105,000,000fully sold56$1.8MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Vignette Bio's Form D filed Sep 13, 2024.

KD
Kenneth Song, M.D.
President and CEO, director

Sources

  1. SECVignette Bio, Inc. filing history